{
    "clinical_study": {
        "@rank": "38539", 
        "arm_group": [
            {
                "arm_group_label": "A (study group)", 
                "arm_group_type": "Active Comparator", 
                "description": "Tandem Colonoscopy- Each patient will undergo 2 colonoscopy procedures:\na Standard view colonoscopy followed immediately by an EndoRings\u2122 colonoscopy."
            }, 
            {
                "arm_group_label": "Group B (control group)", 
                "arm_group_type": "Active Comparator", 
                "description": "Tandem Colonoscopy: Each patient will undergo 2 colonoscopy procedures:\nan EndoRings\u2122 colonoscopy followed immediately by a Standard view colonoscopy."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the adenoma miss rate with the EndoRings\u2122 vs. the adenoma miss rate with Standard\n      view colonoscopy.\n\n      To compare the polyp miss rate with the EndoRings\u2122 vs. the polyp miss rate with Standard\n      view colonoscopy.In addition, time measurements including time to cecum, time for withdrawal\n      and overall procedure time will be analyzed and reported for each group."
        }, 
        "brief_title": "Polyp Detection With the EndoRings\u2122: A Randomized Tandem Colonoscopy Study", 
        "completion_date": {
            "#text": "November 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Colon Cancer", 
        "condition_browse": {
            "mesh_term": "Colonic Neoplasms"
        }, 
        "detailed_description": {
            "textblock": "Patients who are scheduled for screening, surveillance or diagnostic colonoscopy will be\n      recruited to the study and randomized to one of two groups. Each enrolled subject will\n      undergo two \"back-to-back\" procedures.\n\n      Subjects in Group A (study group) will undergo a Standard view colonoscopy followed\n      immediately by an EndoRings\u2122 colonoscopy. Subjects in Group B (control group) will undergo\n      an EndoRings\u2122 colonoscopy followed immediately by a Standard view colonoscopy.\n\n      Results from the two groups will be analyzed and compared, with primary outcome measures\n      being adenoma miss rate and polyp miss rate. Secondary outcome measures will include\n      withdrawal time, total procedure time and characteristics of polyps detected, including size\n      and histological results.\n\n      Subjects will be followed through a 24 hour and a 7-days telephone interview for analysis of\n      unexpected adverse events. Clinical results will be analyzed using various statistical\n      measures of significance.\n\n      Multi-center study with up to 126 patients. Up to 126 treated patients (2 groups of 57\n      patients +6 drop-out patients) will be enrolled into the study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subject between the ages of 40 and 75\n\n          -  The patient is undergoing colonoscopy for screening, for surveillance in follow-up of\n             previous polypectomy or for diagnostic workup;\n\n          -  Written informed consent must be available before enrollment in the trial\n\n        Exclusion Criteria:\n\n          -  Patients with a history of colonic resection;\n\n          -  Patients with known (or newly diagnosed) inflammatory bowel disease;\n\n          -  Patients with a personal history of polyposis syndrome;\n\n          -  Patients with suspected chronic stricture potentially precluding complete\n             colonoscopy;\n\n          -  Patients with diverticulitis or toxic megacolon;\n\n          -  Patients with a history of radiation therapy to abdomen or pelvis;\n\n          -  Patients with a hemorrhagic diathesis\n\n          -  Patients with acute lower GI bleeding\n\n          -  Pregnant women and women with childbearing potential without adequate contraception\n\n          -  Patients who are currently enrolled in another clinical investigation in which the\n             intervention might compromise the safety of the patient's participation in this\n             study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "40 Years"
        }, 
        "enrollment": {
            "#text": "126", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955122", 
            "org_study_id": "TSDPR100"
        }, 
        "intervention": {
            "arm_group_label": [
                "A (study group)", 
                "Group B (control group)"
            ], 
            "description": "Each patient will undergo a double procedure: standard colonoscopy using the EndoRings\u2122 add-on device and Standard colonoscopy (without using the EndoRings\u2122 add-on device).", 
            "intervention_name": "Tandem Colonoscopy", 
            "intervention_type": "Device", 
            "other_name": "Colon screening"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "polyp/adenoma miss rate", 
            "colonoscopy add-on device", 
            "enhanced screening"
        ], 
        "lastchanged_date": "May 25, 2014", 
        "location": [
            {
                "contact": {
                    "email": "lrohn@iu.edu", 
                    "last_name": "Liz Rohn, CCRC", 
                    "phone": "317-944-2972"
                }, 
                "facility": {
                    "address": {
                        "city": "Indianapolis", 
                        "country": "United States", 
                        "state": "Indiana", 
                        "zip": "46202"
                    }, 
                    "name": "Indiana University"
                }, 
                "investigator": {
                    "last_name": "Douglas K. Rex, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "jennym@elishahospital.com", 
                    "last_name": "Jenny Maizlish", 
                    "phone": "972-4-8300000"
                }, 
                "facility": {
                    "address": {
                        "city": "Haifa", 
                        "country": "Israel", 
                        "state": "Please Select", 
                        "zip": "34601"
                    }, 
                    "name": "Elisha Medical Center"
                }, 
                "investigator": [
                    {
                        "last_name": "Ian Gralnek, Prof.", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Ori Segol, Dr.", 
                        "role": "Principal Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands"
                    }, 
                    "name": "University Medical Center Utrecht"
                }, 
                "status": "Completed"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Israel", 
                "Netherlands"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Polyp Detection With the EndoRings\u2122: A Randomized Tandem Colonoscopy Study", 
        "overall_official": [
            {
                "affiliation": "EndoAid Ltd.", 
                "last_name": "Meytal Segev, DMD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "Rambam Health Care Campus", 
                "last_name": "Ian Gralnek, Prof.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Carmel Medical Center", 
                "last_name": "Ori Segol, Dr.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "UMC Utrecht", 
                "last_name": "Peter Siersema, Prof.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Indiana University", 
                "last_name": "Douglas K. Rex, Dr.", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Israel: Ministry of Health", 
                "Netherlands: Medical Ethics Review Committee (METC)", 
                "United States: Institutional Review Board"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Standard colonoscopy adenoma miss rate compared to the adenoma miss rate using the EndoRings\u2122. Standard colonoscopy polyp miss rate compared to the polyp miss rate using the EndoRings\u2122", 
            "measure": "Adenoma and polyp miss rate", 
            "safety_issue": "No", 
            "time_frame": "24 hours post procedure"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955122"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Performance of therapeutic interventions, such as biopsies, polypectomies, APC etc.", 
                "measure": "Theraputic interventions", 
                "safety_issue": "No", 
                "time_frame": "24 hours post procedure"
            }, 
            {
                "description": "The following will be recorded: a. Time for intubation to the cecum. b. Time for withdrawal from the cecum to the anal verge. c. Total procedure time A stopwatch will be used for stopping the timing of the procedure for any polypectomy performed and then restarting once the polypectomy is completed, meaning that purely procedure time is measured", 
                "measure": "Procedure time  A stopwatch will be used for stopping the timing of the procedure for any polypectomy performed and then restarting once the polypectomy is completed, meaning that purely procedure time is measured", 
                "safety_issue": "No", 
                "time_frame": "During the procedure"
            }, 
            {
                "description": "Sedation dosage will be recorded", 
                "measure": "Sedation", 
                "safety_issue": "No", 
                "time_frame": "During the procedure"
            }, 
            {
                "description": "Ability to center the scope inside the gastrointestinal tract.", 
                "measure": "Scope centering ability", 
                "safety_issue": "No", 
                "time_frame": "During the procedure"
            }, 
            {
                "description": "Subjective evaluation of the additional area screened by the physician.", 
                "measure": "Colon area screened", 
                "safety_issue": "No", 
                "time_frame": "During the procedure"
            }, 
            {
                "description": "Patient's pain at the end of the procedure will be recorded using VAS scale. Results of 24 hour telephone follow-up to assess for post-procedural patient satisfactory will be recorded on the CRF.", 
                "measure": "Patient satisfaction", 
                "safety_issue": "No", 
                "time_frame": "24 hours post procedure"
            }
        ], 
        "source": "EndoAid", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EndoAid", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}